Cargando…
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019
Autores principales: | Sosa, Lynn E., Njie, Gibril J., Lobato, Mark N., Bamrah Morris, Sapna, Buchta, William, Casey, Megan L., Goswami, Neela D., Gruden, MaryAnn, Hurst, Bobbi Jo, Khan, Amera R., Kuhar, David T., Lewinsohn, David M., Mathew, Trini A., Mazurek, Gerald H., Reves, Randall, Paulos, Lisa, Thanassi, Wendy, Will, Lorna, Belknap, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522077/ https://www.ncbi.nlm.nih.gov/pubmed/31099768 http://dx.doi.org/10.15585/mmwr.mm6819a3 |
Ejemplares similares
-
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
por: Sterling, Timothy R., et al.
Publicado: (2020) -
Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
por: Lardizabal, Alfred A., et al.
Publicado: (2018) -
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
por: Borisov, Andrey S., et al.
Publicado: (2018) -
Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States()
por: Belanger, Annie, et al.
Publicado: (2019) -
Finding and Closing the Gaps in the Tuberculosis Elimination Campaign
por: Reves, Randall
Publicado: (2020)